Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 10/17 10:00:30 pm
140.79 USD   +3.43%
10:13a JOHNSON & JOHNS : Briefly Briefly
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
07:21a JOHNSON & JOHNS : Dow touches another record high point
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
10:13a JOHNSON & JOHNSON : Briefly Briefly
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
07:21a JOHNSON & JOHNSON : Dow touches another record high point
06:02a JOHNSON & JOHNSON : Wins Reversal Of First St. Louis Talc-Cancer Verdict
02:45a JOHNSON & JOHNSON (NYSE : JNJ) reported earnings of $1.90 per share beating Wall..
10/17 JOHNSON & JOHNSON : Missouri appeals court tosses out $72 million dollar Johnson..
10/17 THE LATEST : Appeals court tosses award in talcum powder case
10/17 JOHNSON & JOHNSON : Appeals court tosses $72 million award in talcum powder case
10/17 JOHNSON & JOHNSON : Appeals court tosses $72 million verdict in lawsuit alleging..
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More news
News from SeekingAlpha
07:03a WALL STREET BREAKFAST : Markets Eye China's Party Congress
06:53a RBC raises price target on Johnson & Johnson to $147 on outlook for pharma bu..
10/17 JOHNSON & JOHNSON : Amazing Company, But There Is Something Wrong
10/17 Johnson & Johnson gets court reversal of verdict over talc cancer risks
10/17 Johnson & Johnson (JNJ) Q3 2017 Results - Earnings Call Transcript
Financials ($)
Sales 2017 75 884 M
EBIT 2017 22 951 M
Net income 2017 16 412 M
Debt 2017 17 928 M
Yield 2017 2,38%
P/E ratio 2017 23,49
P/E ratio 2018 18,83
EV / Sales 2017 5,22x
EV / Sales 2018 4,83x
Capitalization 378 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 140 $
Spread / Average Target -0,86%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON18.42%377 880
NOVARTIS13.23%225 650
ROCHE HOLDING LTD.5.20%217 022
PFIZER11.88%215 576
MERCK AND COMPANY7.68%172 423
AMGEN25.17%135 858